World economic growth, the Serum industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Serum market size to maintain the average annual growth rate of 0.0511984932365 from 670.0 million $ in 2014 to 860.0 million $ in 2020, Stratagem Market Insights analysts believe that in the next few years, Serum market size will be further expanded, we expect that by 2026, The market size of the Serum will reach 1090.0 million $.
Overview:
Fetal bovine serum (FBS) comes from the blood drawn from a bovine fetus via a closed system of collection at the slaughterhouse. It is widely used by academic and industrial researchers as a supplement to basal growth medium in cell culture applications. It is harvested from bovine fetuses taken from pregnant cows during slaughter. FBS is a common component of animal cell culture media. Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin and clotting factors, but containing a large number of nutritional and macromolecular factors essential for cell growth.
Market Drivers:
Rising demand for fetal bovine serum for research studies is expected to boost the growth of the global serum market during the forecast period. Fetal bovine serum is both a scientifically and a morally problematical product. For instance, in March 2021, Thermo Fisher Scientific launched Gibco Human Plasma-like Medium (HPLM), that is designed to provide researchers with a realistic view of cell growth within the human body. When supplemented with FBS, HPLM can support cell growth and viability that are comparable to that of conventional basal media formulations supplemented with FBS. Hence, such factors are expected to drive growth of the global serum market. Moreover, rapid growth of the biopharmaceutical industry and increase in investments/funding for research interventions are expected to augment growth of the global serum market over the forecast period.
Market Restraints:
High cost and chances of viral presence in the product and decrease in cattle herd population due to the increasing demand for meat and dairy products around the world are some major factors expected to hamper growth of the global serum market.
Regional Insights:
Among regions, North America is expected to witness significant growth in the global serum market due to increased funding by government, rise in focus to develop biopharmaceuticals, and the presence of leading clinical diagnostics companies in this region. For instance, as per the Center for Strategic and International Studies (CSIS), the previous administration proposed around US$ 134 billion for federal R&D spending in 2020, while the Biden administration is planning to almost double that number, around US$ 250 billion.
Competitive Section:
Major companies involved in the global serum market are Thermo Fisher (Life-Tech), Merck, Sigma-Aldrich, Bioind, Gemini, Biowest, Moregate Biotech, Bovogen, Corning, Wuhan Sanli, Changchun Xinuo, Lanzhou Minhai, South Pacific Sera, Animal Technologies, Tissue Culture Biologicals, among others.
For instance, in March 2021, Merck added a single-use assembly production unit at its Life Science Center in Molsheim, France.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the World, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information,
Section 1: Definition
Section (2 3): Manufacturer Detail
Thermo Fisher (Life-Tech)
Sigma-Aldrich
Merck
Corning
Bovogen
Moregate Biotech
Biowest
Gemini
Bioind
Tissue Culture Biologicals
Animal Technologies
South Pacific Sera
Lanzhou Minhai
Changchun Xinuo
Wuhan Sanli
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
Bovine Serum
FBS
Industry Segmentation
Biological Products
Research
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2020-2026)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
